V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300004529 | 300003168 | null | 74.3 | Curative (C) | 2016-11-23 | 2016-11-27 | EC | N | N | 300024244 | CARBOPLATIN + RT |
| 300004531 | 300003170 | 1.66 | 80 | Neo-adjuvant (N) | 2013-10-06 | 2013-10-20 | ESPAC-4 TRIAL | N | N | 300024248 | CARBOPLATIN + RT |
| 300004532 | 300003170 | 1.61 | null | Curative (C) | 2015-02-07 | 2015-03-05 | CARBOPLATIN + RT | N | Y | 300024248 | TRASTUZUMAB |
| 300004533 | 300003171 | 1.55 | 43.8 | Disease modification (D) | 2016-06-03 | 2016-06-21 | Fluorouracil + Folinic Acid Weekly | 02 | N | 300024267 | CISPLATIN + TOPOTECAN |
| 300004534 | 300003172 | 1.57 | 56 | Palliative (P) | null | 2018-04-15 | IPILIMUMAB + NIVOLUMAB | null | null | 300024268 | CAPECITABINE + RT |
| 300004535 | 300003172 | 1.86 | null | null | null | 2016-02-19 | Bevacizumab 5mg/kg | N | N | 300024268 | IRINOTECAN + MDG |
| 300004536 | 300003172 | 0 | 104 | Curative (C) | 2018-03-12 | 2018-03-12 | TEMOZOLOMIDE | N | N | 300024268 | ABC-02 TRIAL |
| 300004537 | 300003172 | 1.69 | 89.2 | Curative (C) | 2016-12-28 | 2017-01-11 | ESPAC-4 TRIAL | Y | N | 300024268 | CARBOPLATIN + RT |
| 300004538 | 300003172 | 1.74 | 112.2 | Palliative (P) | 2016-02-17 | 2016-03-09 | DARS Trial | N | N | 300024268 | CARBO + FLUOROURACIL |
| 300004539 | 300003172 | 1.52 | 57 | Curative (C) | 2016-10-18 | 2016-10-20 | null | 2 | Y | 300024268 | EOX |
| 300004540 | 300003172 | 1.48 | 67.3 | Curative (C) | 2013-09-30 | 2013-10-21 | PEMBROLIZUMAB | 02 | N | 300024268 | IPILIMUMAB |
| 300004541 | 300003172 | 1.6 | 58.8 | null | 2016-04-12 | 2016-04-18 | PEMBROLIZUMAB | 02 | null | 300024268 | ESPAC TRIAL |
| 300004542 | 300003173 | 1.86 | 81 | Disease modification (D) | 2014-03-03 | 2014-03-30 | ESPAC-4 TRIAL | 02 | N | 300024293 | CARBOPLATIN + ETOPOSIDE |
| 300004543 | 300003174 | 1.52 | 1.53 | Disease modification (D) | 2017-05-31 | 2017-06-20 | Carboplatin + Etoposide IV 5 day | N | Y | 300024294 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004544 | 300003175 | 1.74 | 62.1 | Adjuvant (A) | 2014-05-19 | 2014-05-28 | Oxaliplatin + Modified de Gramont | N | N | 300024299 | TCF |
| 300004545 | 300003176 | 1.69 | 3.7 | Disease modification (D) | 2016-09-25 | 2016-10-09 | Bevacizumab | N | N | 300024300 | HYDROXYCARBAMIDE |
| 300004546 | 300003176 | null | null | Palliative (P) | 2013-09-25 | 2013-09-27 | Folfirinox | 02 | N | 300024300 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004547 | 300003177 | null | 73.2 | Adjuvant (A) | 2016-04-11 | 2016-04-11 | FLUOROURACIL + OXALIPLATIN | 02 | N | 300024305 | GEMCARBO |
| 300004550 | 300003179 | 1.65 | 81.6 | Adjuvant (A) | 2016-09-30 | 2016-10-07 | Carboplatin AUC 6 - 10 | null | null | 300024317 | BENDAMUSTINE + RITUXIMAB |
| 300004551 | 300003180 | 1.69 | 88 | Curative (C) | 2014-11-28 | 2014-12-17 | DE-ESCALATE TRIAL | N | N | 300024327 | FLUOROURACIL |
| 300004552 | 300003181 | 1.58 | null | Palliative (P) | 2014-05-05 | 2014-05-05 | Cisplatin + Pemetrexed | 02 | N | 300024331 | FLUOROURACIL + MITOMYCIN + RT |
| 300004553 | 300003182 | 1.49 | 93 | Disease modification (D) | null | 2015-04-24 | CHOP - 21 days | N | N | 300024335 | RUXOLITINIB |
| 300004554 | 300003183 | null | null | Palliative (P) | 2014-01-13 | 2014-02-05 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 300024337 | CARBOPLATIN + ETOPOSIDE |
| 300004555 | 300003184 | 1.66 | 76.3 | Adjuvant (A) | 2014-10-22 | 2014-10-22 | ESPAC-4 TRIAL | 02 | N | 300024339 | BEVACIZUMAB |
| 300004557 | 300003186 | 1.6 | 46 | Neo-adjuvant (N) | 2015-11-07 | 2015-11-07 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | null | 300024349 | PEMBROLIZUMAB |
| 300004559 | 300003188 | 1.75 | 52.8 | Curative (C) | 2017-08-12 | 2017-09-09 | GEMCARBO | 02 | Y | 300024359 | CAPECITABINE + GEMCITABINE |
| 300004560 | 300003189 | 1.8 | 65 | Adjuvant (A) | 2017-07-01 | 2017-07-01 | Cisplatin + Fluorouracil + RT 5day | N | null | 300024361 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004561 | 300003190 | 1.81 | 77.3 | null | 2013-04-02 | 2013-04-02 | Carboplatin + Docetaxel | N | null | 300024366 | CAPECITABINE + GEMCITABINE |
| 300004562 | 300003191 | 1.76 | 62.3 | Curative (C) | 2014-08-25 | 2014-09-02 | CARBOPLATIN + RT | 02 | Y | 300024372 | CAPECITABINE + RT |
| 300004564 | 300003193 | 1.81 | 69.75 | Palliative (P) | 2017-06-23 | 2017-07-06 | Carbo F | 02 | N | 300024375 | CARBOPLATIN + RT |
| 300004565 | 300003193 | 1.79 | 101.3 | Palliative (P) | 2017-03-12 | 2017-03-12 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 300024375 | ICON TRIAL |
| 300004566 | 300003194 | 1.63 | 53 | Adjuvant (A) | 2015-06-09 | 2015-06-24 | Gemcitabine + Capecitabine | 02 | N | 300024382 | OXALIPLATIN + MDG |
| 300004567 | 300003195 | 1.86 | 0 | Adjuvant (A) | 2016-08-07 | 2016-08-11 | Capecitabine + Cisplatin | N | N | 300024383 | CARBOPLATIN + RT |
| 300004568 | 300003195 | 1.57 | 50.6 | Palliative (P) | null | 2017-11-24 | FLUOROURACIL + MITOMYCIN | N | N | 300024383 | CARBOPLATIN |
| 300004569 | 300003195 | 1.6 | 3.7 | Curative (C) | 2015-06-14 | 2015-06-18 | FLUOROURACIL + MITOMYCIN + RT | 2 | Y | 300024383 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004570 | 300003196 | 1.58 | 66.5 | Adjuvant (A) | null | 2017-07-20 | Carboplatin + Etoposide iv&po | null | null | 300024392 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 300004571 | 300003196 | null | 98.15 | null | 2017-07-19 | 2017-07-28 | FLUOROURACIL | N | Y | 300024392 | GEMCARBO |
| 300004572 | 300003197 | 1.49 | 61 | Curative (C) | null | 2016-11-20 | PEMBROLIZUMAB | N | Y | 300024396 | FLUOROURACIL + MITOMYCIN |
| 300004573 | 300003197 | null | 90.9 | Adjuvant (A) | 2016-03-24 | 2016-04-10 | Docetaxel 75mg/m2 (21 day) | N | N | 300024396 | CAPECITABINE + OXALIPLATIN |
| 300004574 | 300007475 | 1.75 | null | Palliative (P) | 2014-09-19 | 2014-09-19 | Folfirinox | N | null | 300024401 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004575 | 300003198 | 1.5 | 76 | Disease modification (D) | 2015-03-08 | 2015-04-26 | CARBOPLATIN + RT | N | N | 300024404 | FLUOROURACIL + MITOMYCIN |
| 300004576 | 300003199 | 1.58 | 117.7 | Neo-adjuvant (N) | 2013-06-27 | 2013-07-11 | CAPECITABINE + OXALIPLATIN | N | N | 300024405 | DOCETAXEL |
| 300004577 | 300003200 | 1.7 | 85 | Neo-adjuvant (N) | 2016-08-10 | 2016-08-23 | Carbo F | 02 | null | 300024413 | CARBOPLATIN |
| 300004578 | 300003201 | 1.52 | 53 | Disease modification (D) | 2013-01-18 | 2013-01-21 | FLUOROURACIL + MITOMYCIN + RT | N | N | 300024415 | FEC + DOCETAXEL |
| 300004579 | 300006148 | 1.83 | 84 | Palliative (P) | 2016-08-29 | 2016-09-11 | Gemcitabine + Capecitabine | 2 | N | 300024417 | TEMOZOLOMIDE + RT |
| 300004580 | 300003202 | 1.57 | 75.4 | Curative (C) | 2017-04-21 | 2017-04-22 | null | 01 | N | 300024420 | DE-ESCALATE TRIAL |
| 300004581 | 300003203 | 1.7 | 81.6 | Curative (C) | 2015-07-08 | 2015-07-15 | Carboplatin + Docetaxel | N | N | 300024423 | CARBOPLATIN + ETOPOSIDE |
| 300004582 | 300003204 | null | null | Curative (C) | 2017-07-12 | 2017-07-25 | FLUOROURACIL + MITOMYCIN | N | N | 300024428 | FLUOROURACIL + MITOMYCIN + RT |
| 300004583 | 300003204 | 1.75 | 52.8 | Adjuvant (A) | 2015-12-23 | 2016-01-05 | CARBOPLATIN + RT | 02 | N | 300024428 | CARBO + FLUOROURACIL |
| 300004584 | 300003204 | null | null | Curative (C) | 2014-09-16 | 2014-09-30 | Hydroxycarbamide | 2 | Y | 300024428 | CARBOPLATIN + ETOPOSIDE |